North America Epigenetics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

1. INTRODUCTION

• 1.1 Study Assumptions
• 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Burden of Cancer Diseases
  • 4.2.2 Increasing Investments into Research and Development Activities
  • 4.2.3 Rising Epigenetic Applications in Non-oncology Diseases
• 4.3 Market Restraints
  • 4.3.1 Presence of Stringent Regulatory Framework
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

• 5.1 By Product
  • 5.1.1 Instruments
  • 5.1.2 Reagents & Kits
  • 5.1.3 Others
• 5.2 By Applications
  • 5.2.1 Oncology
  • 5.2.2 Autoimmune Diseases
  • 5.2.3 Metabollic Diseases
  • 5.2.4 CNS/Pain Diseases
  • 5.2.5 Cardiovascular Diseases
  • 5.2.6 Others
• 5.3 By Technology
  • 5.3.1 Methylation
  • 5.3.2 Acetylation
  • 5.3.3 Phosphorylation
  • 5.3.4 Others
• 5.4 By Geography
  • 5.4.1 North America
  • 5.4.1.1 United States
  • 5.4.1.2 Canada
  • 5.4.1.3 Mexico

6. COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Abcam PLC
  • 6.1.2 Active Motiff
  • 6.1.3 Diagenode Inc.
  • 6.1.4 F. Hoffmann-La Roche Ltd
  • 6.1.5 Illumina Inc.
  • 6.1.6 Qiagen N.V.
  • 6.1.7 Merck KGaA
  • 6.1.8 TherFisher Scientific
  • 6.1.9 Zyhmo Research Corporation
• *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS